Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-05-17

FDA Approved: AIMOVIG — Original Application (Amgen Inc)

View source ↗

Summary

FDA approved AIMOVIG (erenumab) from Amgen as an original application for the preventive treatment of migraine in adults. This marks the initial regulatory appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AIMOVIG (ERENUMAB-AOOE)

Snippet

ORIG AP for AIMOVIG (ERENUMAB-AOOE)